Jana Hundertmark - Search Results

Year	Number of Results
2018	1
2019	2
2020	4
2021	1
2022	2

1

Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages^☆.

Lefere S, Puengel T, Hundertmark J, Penners C, Frank AK, Guillot A, de Muynck K, Heymann F, Adarbes V, Defrêne E, Estivalet C, Geerts A, Devisscher L, Wettstein G, Tacke F. Lefere S, et al. Among authors: hundertmark j. J Hepatol. 2020 Oct;73(4):757-770. doi: 10.1016/j.jhep.2020.04.025. Epub 2020 Apr 29. J Hepatol. 2020. PMID: 32360434

2

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis.

Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F. Krenkel O, et al. Among authors: hundertmark j. Cells. 2019 May 24;8(5):503. doi: 10.3390/cells8050503. Cells. 2019. PMID: 31137713 Free PMC article.

3

Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis.

Krenkel O, Hundertmark J, Abdallah AT, Kohlhepp M, Puengel T, Roth T, Branco DPP, Mossanen JC, Luedde T, Trautwein C, Costa IG, Tacke F. Krenkel O, et al. Among authors: hundertmark j. Gut. 2020 Mar;69(3):551-563. doi: 10.1136/gutjnl-2019-318382. Epub 2019 May 10. Gut. 2020. PMID: 31076404

4

How effective are nonalcoholic fatty liver disease models for drug discovery?

Hundertmark J, Tacke F. Hundertmark J, et al. Expert Opin Drug Discov. 2020 Nov;15(11):1237-1240. doi: 10.1080/17460441.2020.1776258. Epub 2020 Jun 11. Expert Opin Drug Discov. 2020. PMID: 32524859

5

Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases.

Bruneau A, Hundertmark J, Guillot A, Tacke F. Bruneau A, et al. Among authors: hundertmark j. Front Med (Lausanne). 2021 Sep 28;8:725390. doi: 10.3389/fmed.2021.725390. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34650994 Free PMC article. Review.

6

Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease.

Hundertmark J, Krenkel O, Tacke F. Hundertmark J, et al. Front Immunol. 2018 Oct 18;9:2418. doi: 10.3389/fimmu.2018.02418. eCollection 2018. Front Immunol. 2018. PMID: 30405618 Free PMC article. Review.

7

Single Cell RNA Sequencing in NASH.

Hundertmark J, Berger H, Tacke F. Hundertmark J, et al. Methods Mol Biol. 2022;2455:181-202. doi: 10.1007/978-1-0716-2128-8_15. Methods Mol Biol. 2022. PMID: 35212995

8

The Medium-Chain Fatty Acid Receptor GPR84 Mediates Myeloid Cell Infiltration Promoting Steatohepatitis and Fibrosis.

Puengel T, De Vos S, Hundertmark J, Kohlhepp M, Guldiken N, Pujuguet P, Auberval M, Marsais F, Shoji KF, Saniere L, Trautwein C, Luedde T, Strnad P, Brys R, Clément-Lacroix P, Tacke F. Puengel T, et al. Among authors: hundertmark j. J Clin Med. 2020 Apr 16;9(4):1140. doi: 10.3390/jcm9041140. J Clin Med. 2020. PMID: 32316235 Free PMC article.

9

Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis.

Puengel T, Lefere S, Hundertmark J, Kohlhepp M, Penners C, Van de Velde F, Lapauw B, Hoorens A, Devisscher L, Geerts A, Boehm S, Zhao Q, Krupinski J, Charles ED, Zinker B, Tacke F. Puengel T, et al. Among authors: hundertmark j. Int J Mol Sci. 2022 Jun 15;23(12):6696. doi: 10.3390/ijms23126696. Int J Mol Sci. 2022. PMID: 35743140 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results